# Efficacy and Safety of BtH Body 2.2% (Injectable Hyaluronic Acid) in Volumizing and Contouring Large Areas of the Body: Prospective Clinical Investigation.

> **NCT07441135** · NA · NOT_YET_RECRUITING · sponsor: **i+Med S.Coop.** · enrollment: 80 (estimated)

## Conditions studied

- Aesthetic Body Volume Loss

## Interventions

- **DEVICE:** BtH Body 2.2%

## Key facts

- **NCT ID:** NCT07441135
- **Lead sponsor:** i+Med S.Coop.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07441135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07441135, "Efficacy and Safety of BtH Body 2.2% (Injectable Hyaluronic Acid) in Volumizing and Contouring Large Areas of the Body: Prospective Clinical Investigation.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07441135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*